Mylan CEO: 55% of EpiPen price goes toward insurers, pharmacy ...

Becker's Hospital Review-7 minutes ago

Mylan CEO Heather Bresch continues to defend the high cost of EpiPens by pointing out that middlemen in the drug's supply chain take 55 percent of th